HIF1A and pulmonary arterial hypertension: Enhanced HIF-1 activity helps to promote angiogenesis, erythropoiesis, and vasodilation, thereby potentially attenuating some PAH pathological changes, such as pulmonary vascular remodeling and hypertension.